Arkolith/Insider Trading/ALLO/Form 4

Roberts Zachary

EVP of R&DAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Jan 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$48K
Net Open-Market Flow
-$48K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2025Sell(S)27K$1.78$48K488K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001737287-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML